Testagen Dosage, Reconstitution & Mixing Trends

Explore testagen calculator-entry dose, vial-size, BAC-water and self-reported frequency distributions. Research context is separate from live observations.

Anonymized testagen calculator entries are summarized by each chart's selected period. Frequency responses come from the separate vial-duration feature. Inputs are not verified administrations or unique people.

What Testagen Is

Testagen is a synthetic dipeptide (Glu-Trp) from the Khavinson short-peptide bioregulator program, sourced for male reproductive and androgen-aging research. It ships as a lyophilized powder you reconstitute with bacteriostatic water, and is catalogued with the same Glu-Trp sequence as the thymic peptide Thymogen.[1][4]

In the Khavinson framework, Testagen is proposed to act through direct binding to gene-promoter DNA in testicular Leydig and Sertoli cells, selectively modulating transcription of genes involved in spermatogenesis, androgen biosynthesis, and apoptosis regulation.[2] This proposed direct-DNA-binding mechanism is unconventional and has not been independently characterised outside the Khavinson group.

Russian single-site studies have reported Testagen in age-related androgen decline, oligospermia, and male infertility contexts in elderly patients, with reported improvements in sperm-count, motility, and androgen-axis markers versus standard care.[3] These studies are not blinded or placebo-controlled, and no Western Phase 2 or 3 trial has been registered.

Not FDA-approved for any indication. Sold in Russia as a non-prescription dietary peptide; research-grade injectable material elsewhere.

Testagen Research Sources

Testagen Dosing Context

Testagen has a reported half-life of ~30 min (short-peptide estimate). The pharmacokinetic reference models an interval of once daily (in 10–20 day courses); this is not a measured community cadence or a dosing recommendation. This short Khavinson peptide clears within an hour with no systemic buildup; its bioregulator effect is thought to come from the full course rather than a steady level. Pharmacokinetic source: No published human PK; Khavinson short-peptide bioregulator estimate. It is catalogued under Testosterone Peptides on WPA.

Testagen Community Calculator Data

22 Testagen reconstitution calculations have been logged by the WPA community.

This is the lifetime header population. Each chart and its associated analysis below use their own selected period and denominator; frequency responses are a separate cohort.

These figures come from anonymized WPA peptide calculator sessions, not verified administrations or unique people. Separate modal inputs do not establish a joint protocol. They are community input statistics — not dosing recommendations, and not medical advice.

WPA Analysis

Testagen Research Background and Calculator Data

Testagen is a synthetic tetrapeptide (Lys-Glu-Asp-Gly) developed at the St. Petersburg Institute of Bioregulation and Gerontology under Vladimir Khatskelevich Khavinson as part of the organ-specific short-peptide bioregulator program, with a specific tissue target: testicular tissue and Leydig cell function. Within the broader Khavinson framework — which proposes that very short organ-specific oligopeptides exert tissue-targeted epigenetic regulation by binding gene-promoter regions in the same tissue from which they were originally derived — Testagen is positioned as the synthetic peptide derived from the parent multi-peptide testicular extract, with the published Khavinson-group preclinical work focused on testosterone biosynthesis support and Leydig cell function in aged rodent models. The clinical literature on Testagen specifically is among the smallest in the Khavinson short-peptide family — substantially thinner than for Thymalin, Vilon, or Prostamax — and consists primarily of small Russian-language reports rather than controlled trials. Testagen holds no FDA or EMA approval in any jurisdiction, and there is no published controlled human study of the molecule outside the Russian Khavinson corpus.

Research background is separate from the calculator observations below. Calculator entries do not establish administration, safety, effectiveness, or the reasons for an input.

WPA DOSING INSIGHT

Dose and Frequency Calculator Inputs

The summaries use each chart's own period and, for frequency responses, its dose filter. Separate cohorts must not be combined into a protocol.

WPA RECONSTITUTION INSIGHT

Vial Size and BAC Water Calculator Inputs

Vial-size and BAC-water observations describe separate input distributions, not purchases or verified preparations. Separate modal inputs do not establish a joint protocol.

These figures come from anonymized WPA peptide calculator sessions.

All figures shown are aggregated from anonymized calculator inputs and are provided strictly for independent laboratory research and educational purposes. They are community usage statistics — not dosing recommendations, and not medical advice.